ClinicalTrials.gg
CompletedNCT07755332Updated Aug 11, 2026

Association Between Central Sensitization and the Root Mean Square of Successive Differences

An observational study in Healthy Participants, sponsored by Istanbul Demiroglu Bilim University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by Istanbul Demiroglu Bilim University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
45
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The aim of this study was to examine the relationship between central sensitization and resting RMSSD (Root Mean Square of Successive Differences) in individuals exhibiting prolonged sitting behavior, controlling for potential confounding factors such as age, gender, and body mass index; and to evaluate whether participants, grouped according to sitting durations, differed in terms of RMSSD, central sensitization, balance, and executive cognitive function.

Read the detailed description

A sedentary lifestyle is becoming increasingly prevalent throughout society. Particularly in populations associated with prolonged sitting, while the cause of chronic pain is often attributed to mechanical factors, it is emphasized that central sensitization also plays a significant role in the pathophysiology of chronic pain. Given the multifaceted effects of central sensitization, heart rate variability (HRV)-a marker of balance, executive function, and autonomic function-gains importance. This study examined the relationship between participants' dynamic balance, Root Mean Square of Successive Differences (RMSSD)-one of the measurement parameters related to HRV-cognitive executive function, and central sensitization assessments. The findings are intended to shed light on clinical assessment and ergonomic intervention strategies for desk-based workers.

02

Conditions studied

  • Healthy Participants

Keywords

  • postural balance
  • executive function
  • central sensitization
03

In context

Lead sponsor

Istanbul Demiroglu Bilim University is the lead sponsor of 22 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consisted of healthy young adults aged 18-45 years who spent at least 30 hours sitting per week.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age range: Between 18 and 45 years of age.
  • Sitting time: Having at least 30 hours of sitting time per week.
  • Voluntary participation: Voluntarily agreeing to participate in the study.
  • Cognitive and sensory capacity: Having the cognitive, auditory, and visual capacity to understand the study procedures and perform the tasks.
  • Physical fitness: Not having any physical condition that would prevent the use of the HRV measuring device.

Exclusion criteria

Exclusion Criteria:

  • Having any cardiovascular, neurological, or systemic disease that interferes with physical activity,
  • Using medications that may affect the autonomic nervous system within the last month,
  • Having a history of cognitive impairment,
  • Having engaged in strenuous exercise or had a febrile illness within the last 24 hours,
  • Having a clinically diagnosed central sensitization syndrome,
  • Being pregnant
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
45 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthy participants

    Individuals who were between the ages of 18-45, had at least 30 hours of sitting time per week, agreed to participate voluntarily, and met the inclusion criteria participated.

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Demographic Information Collection

    Demographic information of the participants was collected using a participant assessment form developed by the research team. The form collected information about age, height, weight, body mass index, gender, education level, and weekly sitting time.

    Time frame: Baseline (Single Assessment)

  2. Assessment of Central Sensitization

    Central sensitivity was assessed using the Central Sensitivity Inventory. The scale ranges from 0 to 100, with higher scores indicating more severe symptoms.

    Time frame: Baseline (Single Assessment)

  3. Assessment of Heart Rate Variability

    Heart rate variability measurements were recorded at rest for 5 minutes using a Polar H10 device, in accordance with the recommendations of the European Society of Cardiology. The device was secured to the lower sternal notch with a belt. The RMSSD (Root Mean Square of Successive Differences, ms) parameter was used as an indicator of vagal activity.

    Time frame: Baseline (Single Assessment)

Secondary outcomes

  1. Assessment of Balance

    The Y Balance Test was used in the balance assessment. First, leg length was determined. Participants were asked to reach as far as possible in the anterior, posteromedial, and posterolateral directions with their other foot, while keeping their test foot at the center point. The reach distances were normalized using the formula \[(Best reach distance / Leg length) × 100\], and the composite balance score was calculated by averaging the results from all three directions.

    Time frame: Baseline (Single Assessment)

  2. Assessment of cognitive/executive function

    The Verbal Fluency Test was used to assess cognitive/executive function. To measure semantic fluency, the category of animals was used, and the individual was asked to name animals for one minute. For phonemic fluency assessment, the letters 'k, a, s' were selected, and the words spoken using these letters were noted. When calculating the number of correct words, 1 point was given for each word produced according to the instructions.

    Time frame: Baseline (Single Assessment)

07

Study locations

1 site
  • Demiroglu Bilim University
    Istanbul, Istanbul 34570, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to confidentiality agreements and ethical restrictions.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2026 to primary completion in Apr 2026, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2026
First posted
Aug 10, 2026
StartActual
Jan 1, 2026
Primary completionActual
Apr 1, 2026
CompletionActual
Apr 1, 2026
Last update
Aug 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07755332
Lead sponsor
Istanbul Demiroglu Bilim University
Responsible party
Selin Akıl Ağdere (Asst. Prof., Istanbul Demiroglu Bilim University) — Principal investigator
First posted
Aug 10, 2026
Start date
Jan 1, 2026
Primary completion
Apr 1, 2026
Completion
Apr 1, 2026
Last update
Aug 11, 2026

Study contacts

Selin Akil Agdere, Asst. Prof.
study director · Istanbul Demiroglu Bilim University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion